This systematic review evaluates the use of methylene blue (MB) in managing vasoplegic shock, particularly in critical care, liver transplantation, and cardiac anesthesia. While MB has shown consistent blood pressure improvement in small studies and case reports, its effect on mortality and oxygen delivery remains inconclusive. The review stresses the
